News Molecular Templates, Inc.

Equities

MTEM

US6085502085

Market Closed - Nasdaq Other stock markets 02:00:00 27/04/2024 am IST			5-day change	1st Jan Change
1.705 ^USD	+6.56%		+15.99%	-54.29%

12/04	Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024	CI
09/04	Molecular Templates, Inc. Presents Interim Data from Mt-6402 Phase I Study in Patients with Pd-L1+ Solid Tumors At the 2024 American Association for Cancer Research Annual Meeting	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024	13/04	CI
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism	09/04	AQ
Molecular Templates, Inc. Presents Interim Data from Mt-6402 Phase I Study in Patients with Pd-L1+ Solid Tumors At the 2024 American Association for Cancer Research Annual Meeting	09/04	CI
Molecular Templates, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update	29/03	AQ
Molecular Templates, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03	CI
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement	28/03	AQ
North American Morning Briefing: Investors Balance AI Hopes with Rate Concerns	18/03	DJ
Molecular Templates, Inc. Provides Interim Update	04/03	AQ
Molecular Templates, Inc. Provides Interim Update	04/03	CI
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	09/02	AQ
Molecular Templates, Inc. Announces Board Changes	18/01	CI
Molecular Templates, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Earnings Flash (MTEM) MOLECULAR TEMPLATES Reports Q3 Revenue $6.8M	14/11	MT
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update	14/11	AQ
Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors	03/11	AQ
Molecular Templates, Inc. Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors	03/11	CI
Molecular Templates to Participate in Upcoming Investor Conferences	02/11	AQ
Molecular Templates Names Chief Medical Officer	29/23/29	MT
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer	29/23/29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Molecular Templates, Inc.

Equities

MTEM

US6085502085

Summary

Filters